Bio-Connect
Western blot analysis of extracts from HepG2 cells, using ADARB1 antibody.
Western blot analysis of extracts from HepG2 cells, using ADARB1 antibody.
Western blot analysis of extracts from HepG2 cells, using ADARB1 antibody.

ADARB1 Antibody

CSB-PA949783
Cusabio
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetADARB1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cusabio
  • Product Name
    ADARB1 Antibody
  • Delivery Days Customer
    20
  • Applications
    Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID104
  • Target name
    ADARB1
  • Target description
    adenosine deaminase RNA specific B1
  • Target synonyms
    ADAR2; adenosine deaminase, RNA-specific, B1 (homolog of rat RED1); double-stranded RNA-specific editase 1; DRABA2; DRADA2; dsRNA adenosine deaminase DRADA2; NEDHYMS; RED1; RNA editing deaminase 1; RNA-editing enzyme 1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP78563
  • Protein Name
    Double-stranded RNA-specific editase 1
  • Scientific Description
    Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2 and GRIK2) and serotonin (HTR2C), GABA receptor (GABRA3) and potassium voltage-gated channel (KCNA1). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alter their functional activities. Edits GRIA2 at both the Q/R and R/G sites efficiently but converts the adenosine in hotspot1 much less efficiently. Can exert a proviral effect towards human immunodeficiency virus type 1 (HIV-1) and enhances its replication via both an editing-dependent and editing-independent mechanism. The former involves editing of adenosines in the 5UTR while the latter occurs via suppression of EIF2AK2/PKR activation and function. Can inhibit cell proliferation and migration and can stimulate exocytosis. Mittaz L., Genomics 41:210-217(1997). Lai F., Mol. Cell. Biol. 17:2413-2424(1997). Villard L., Somat. Cell Mol. Genet. 23:135-145(1997).
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C
  • UNSPSC
    12352203